Drugs that contain Abametapir

1. List of Xeglyze drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9839631 DR REDDYS LABS SA Methods and compositions for controlling ectoparasites
Jul, 2024

(1 year, 5 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8212038 DR REDDYS LABS SA Methods and compositions for controlling ectoparasites
Jul, 2024

(1 year, 5 months from now)

US9357783 DR REDDYS LABS SA Methods and compositions for controlling ectoparasites
Jul, 2024

(1 year, 5 months from now)

US7812163 DR REDDYS LABS SA Methods and compositions for controlling ectoparasites
Oct, 2026

(3 years from now)

US10292389 DR REDDYS LABS SA Pediculicidal composition
Dec, 2034

(11 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jul 24, 2025

NCE-1 date: July, 2024

Market Authorisation Date: 24 July, 2020

Treatment: Topical treatment of head lice infestation in patients 6 months of age and older

Dosage: LOTION;TOPICAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in